Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

No demand for new Covid vaccine – “It will probably be discarded”

So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...

Vill ha feedback på riktlinjer för genterapier

EMA har publicerat ett utkast med riktlinjer för bland annat utveckling, kliniska studier och uppföljning av genterapier.

Apoteket gets new vice CEO

The Swedish government company Apoteket has recently appointed a vice CEO.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Visar lovande ny mekanism mot alzheimer

”Vi är nära ett genombrott i kampen mot Alzheimers sjukdom.” Det var budskapet från Pontus Forsell, forskningschef på AlzeCure, vid mötet 17th International Con...

Think outside the... brain

Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.

Strömlinjeformar läkemedelsutveckling

It-jätten Oracle släpper en ny version av sin mjukvara Agile Product Lifecycle Management, PLM.

Swiss allergy therapy convinces

Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.

Pharma Outsourcing igång på Stockholm Waterfront

Almost 150 will leave Coloplast

The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.

Athera signs production partnership

The companys novel cardiovascular product will be manufactured in Germany.

180 cancerforskare samlas digitalt i Lund

Medicon Village och Lunds universitet ordnar ett digitalt möte på Världscancerdagen på torsdag.

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Ny lösning för snabb transfektion

BTXpress är en ny typ av vätska för elektroporering av celler, från BTX products.

How to get visitors to your booth

Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.

Årets medtech-bolag korad

Under Swedish Medtechs höstmöte prisades det medtech-bolag som utmärkt sig särskilt under året.

A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Brighters dotterbolag börsnoteras

Brighters dotterbolag köper upp robotikföretaget Bestic och planerar en börsnotering. Det nya bolaget ska ledas av Bestics nuvarande vd Catharina Borgenstierna.